France· FR:64851088
EXTAVIA 250 microgrammes/mL, poudre et solvant pour solution injectable
A interferon beta-1b product containing interféron bêta-1b, registered in France by NOVARTIS EUROPHARM (IRLANDE). The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Interferon beta-1b is registered in 14 of 19 countries.
Countries holding a registration under ATC L03AB08 (interferon beta-1b), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Interferon beta-1b · ATC L03AB08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- INTERFÉRON BÊTA-1B
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- L03AB08
- ATC class
- Interferon beta-1b
- Defined daily dose
- 4 MIO, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340092699435815 flacon(s) en verre - 15 seringue(s) préremplie(s) en verre de 1,2 ml dans 2,25 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
347 interactions on record for interferon beta-1b.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Interferon beta-1b · interactions on record
347 records
- 15 severe
- 332 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- ZidovudineJ05AF01severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Interferon beta-1b in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBETAFERONBayer AG, Leverkusen
- SpainBETAFERON 250 MICROGRAMOS/ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBayer Ag
- FinlandBetaferonAbacus Medicine A/S
- United KingdomBetaferon 300microgram powder and solvent for solution for injection vialsBayer Plc
- BelgiumBetaferon 0.25 mg/mlBayer
- PolandBetaferonBayer AG
- ItalyBETAFERON*15 flaconcini polvere SC 0,25 mg/ml + 15 siringheBAYER AG
- Japanインターフェロンベータ-1b(遺伝子組換え)バイエル薬品
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Betaferon
- Liechtenstein · Betaferon
- Norway · Betaferon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cba2bf9c-3986-4274-8df4-54218caf227b GET /v1/drugs/cba2bf9c-3986-4274-8df4-54218caf227b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64851088",
"date_amm": "2008-05-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/08/454",
"substance": "INTERFÉRON BÊTA-1B",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about interferon beta-1b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.